Oridonin-derived Compounds as Triple-Negative Breast Cancer Therapeutics
This paper has been withdrawn.
Nov 2nd, 10:10 AM
Nov 2nd, 11:20 AM
Oridonin-derived Compounds as Triple-Negative Breast Cancer Therapeutics
LSUHSC-NO Lion's Building